MyraQuat SRL
Ouverture de faillite 0.7 FTEMyraQuat reported total assets of 107,556 € at the end of the 2022 financial year (annual accounts filed with the NBB on 02 Oct 2023), with 0.7 full-time equivalent.
The score of MyraQuat shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MyraQuat's annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 02 Oct 2023
- Year ended 31 Dec 2021filed on 02 Nov 2022
MyraQuat's financial analysis
- Solvency-22.0%sector median: 60.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MyraQuat
MyraQuat's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0745.906.046
- VAT number
- BE0745906046
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 09 Apr 2020
- Registered office
- 9800 Deinze
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2022 · filed on 02 Oct 2023
- Activity
- Market research and public opinion polling (NACE 73200)
MyraQuat (SRL) has been based in Deinze since 2020, active in: market research and public opinion polling. For 2022, it reports a net loss of 26,511 € and equity of −23,675 €; its revenue is not published. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -22.0%, below the median of its sector (60.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MyraQuat
Companies in the same business, of comparable size and area, outside its group.
- Hansma International Manufacture of basic pharmaceutical products Bonheiden · balance sheet 75,376 €
- International Mushroom Consulting Jans Market research and public opinion polling Kinrooi · balance sheet 355,308 €
- Lanceo Manufacture of basic pharmaceutical products Vorselaar · balance sheet 291,955 €
- Harika Lifij Manufacture of basic pharmaceutical products Evere · balance sheet 105,370 €
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- Rodilo Manufacture of pharmaceutical preparations Liège · balance sheet 204,587 €
Frequently asked questions about MyraQuat
What is the revenue of MyraQuat?
MyraQuat files its accounts in a format where revenue is optional: it is not published for 2022.
What is the VAT number of MyraQuat?
In Belgium, the VAT number is the company number prefixed with BE: BE0745906046 for MyraQuat, if the company is VAT-registered. Its company number (CBE) is 0745.906.046.
Where is the registered office of MyraQuat?
According to the CBE register, the registered office of MyraQuat is in 9800 Deinze.
What is the equity of MyraQuat?
At the close of the 2022 financial year, the equity of MyraQuat amounts to -23,675 €, a solvency of -22.0% of total assets.
How many people work at MyraQuat?
0.7 full-time equivalents on average according to the 2022 social balance sheet.
Who manages MyraQuat?
The register lists 5 active mandates at MyraQuat. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MyraQuat
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →